Concepedia

J.Blonk van der Wijst

JV

Statistics

Publications

4

Citations

92

H-Index

4

Active since

1975

Affiliations

Institut Jules Bordet(Current)

Rotterdam University of Applied Sciences

J.Blonk van der Wijst is an author at Institut Jules Bordet specializing in breast cancer hormonal therapy, breast oncology, and medicine.

Publications per year

1975–1985

4

Publications

4

Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer

Jan G.M. Klijn, Frank H. de Jong, Marinus A. Blankenstein et al. · Breast Cancer Research and Treatment · 1984 · 43 citations

, , +16

Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.

E Engelsman, Jean-Claude Heuson, J.Blonk van der Wijst et al. · BMJ · 1975 · 29 citations · Full text

, , +8

Aminoglutethimide and estrogenic stimulation before chemotherapy for treatment of advanced breast cancer. preliminary results of a phase II study conducted by the E.O.R.T.C. breast cancer cooperative group

Robert Paridaens, J.Blonk van der Wijst, J.P. Julien et al. · Journal of Steroid Biochemistry · 1985 · 10 citations

, , +12

Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study)

J. Alexieva-Figusch, Wim L.J. van Putten, H.A. van Gilse et al. · Medical Oncology and Tumor Pharmacotherapy · 1985 · 10 citations

, , +16

1–4 of 4